Last reviewed · How we verify

NCT03801772

Effects of a Metronome on Functional Outcomes in Aquatic Therapy

Completed NA Last updated 2 September 2021
What this trial tests

NA trial testing Metronome in Exercise Therapy in 100 participants. Completed in 16 April 2021.

Timeline
21 January 2019
Primary endpoint
31 December 2019
16 April 2021

Quick facts

Lead sponsorAultman Health Foundation
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment100
Start date21 January 2019
Primary completion31 December 2019
Estimated completion16 April 2021
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Aultman Health Foundation

Who can join

18 and older, any sex, with Exercise Therapy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to determine if the use of a pacing device, a metronome, improves functional outcome measures in aquatic therapy when compared to a control group.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Metronome

Trials testing the same drug.

Other recruiting trials for Exercise Therapy

Currently open trials in the same condition.

Other Aultman Health Foundation trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03801772.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing